英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
blurs查看　blurs　在百度字典中的解释百度英翻中〔查看〕
blurs查看　blurs　在Google字典中的解释Google英翻中〔查看〕
blurs查看　blurs　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • PROVENGE® (sipuleucel-T)
    PROVENGE is personal PROVENGE is the first FDA-approved personalized immunotherapy for treatment of advanced prostate cancer It has been clinically proven to extend life for certain men with mCRPC As a personalized immunotherapy, PROVENGE works differently from other cancer treatments, such as chemotherapy or hormone therapy
  • Questions and Answers - Provenge | FDA
    PROVENGE (sipuleucel-T) is an autologous cellular immunotherapy designed to stimulate a patient’s own immune system against cancer
  • Provenge for Prostate Cancer: Uses, Dosage Side Effects . . .
    Provenge (sipuleucel-T) is a personalized immunotherapy used to treat advanced prostate cancer Includes Provenge side effects, process, interactions and indications
  • Provenge® - Frequently Asked Questions - Dana-Farber Cancer . . .
    What is Provenge? Provenge is the first therapeutic cancer vaccine to receive approval from the U S Food and Drug Administration FDA approval means it can now be part of the standard treatment for certain prostate cancer patients, rather than being used only in clinical research studies How does Provenge work? As a vaccine, Provenge harnesses the body's immune system to fight cancer Unlike
  • Why Provenge Failed Despite Its Scientific Breakthrough
    Sipuleucel-T, marketed as Provenge, was the first therapeutic cancer vaccine approved by the U S Food and Drug Administration (FDA) in 2010 Its approval for prostate cancer treatment represented a landmark scientific achievement, heralding a new era of immunotherapy and personalized medicine Despite this revolutionary status, Provenge failed commercially, leading to the financial collapse
  • Sipuleucel-T - Wikipedia
    Sipuleucel-T, sold under the brand name Provenge, developed by Dendreon Pharmaceuticals, LLC, is a cell-based cancer immunotherapy for prostate cancer (CaP) [1][3][4] It is an autologous cellular immunotherapy
  • Provenge Advanced Prostate Cancer Treatment - UCLA Health
    Provenge Therapy, Advanced Prostate Cancer Treatment Urologists at UCLA Urology are offering Provenge, a treatment option for advanced prostate cancer UCLA Urologists were collaborators on clinical trials that helped lead to the U S Food and Drug Administration (FDA) approval of Provenge in 2010, and have been treating patients with Provenge at the Clark Urology Center since 2003
  • Provenge: Cost, side effects, uses, how it works, and more
    Provenge (sipuleucel-T) is a prescription drug that treats prostate cancer in adult males Learn about cost, side effects, uses, how it works, and more
  • Prostate Cancer Immunotherapy | Dendreon
    PROVENGE ® (sipuleucel-T) PROVENGE ® (sipuleucel-T) has been available in the United States since 2010 It is the first and only FDA-approved immunotherapy for the treatment of advanced prostate cancer made from a patient’s own immune cells This groundbreaking treatment has been prescribed to nearly 40,000 men with advanced prostate cancer, helping many live longer For more information
  • Sipuleucel-T — Grokipedia
    Sipuleucel-T, marketed as Provenge, is an autologous cellular immunotherapy designed to stimulate a patient's immune system to target prostate cancer cells expressing prostatic acid phosphatase (PAP),





中文字典-英文字典  2005-2009